W. Rush Scaggs is a Senior Scientific Lead in Medicinal Chemistry at Eli Lilly and Company since 2023. Previously, Scaggs served as a Postdoctoral Researcher at Vanderbilt University from 2020 to 2022, focusing on structure-based drug design towards PROTACs. They also conducted research as a Graduate Student Researcher at Indiana University from 2014 to 2019, specializing in asymmetric catalysis, and worked as an Undergraduate Researcher at both the University of Texas at Arlington and Indiana University, contributing to studies on catalyzed reactions and chiral HPLC separation.
This person is not in any teams
This person is not in any offices